L Carnitine Infusion Versus Oral Supplementation Mitochondrial Myopathy

Anon. Carnitine may boost T cell counts. Treatment Update 10(5) (1998): 4-6.

Bach AC et al. Free and total carnitine in human serum after oral ingestion of L-carnitine. Diabet Metab 9 (1983): 121-4.

Baker H, DeAngelis B, Orlando J, Correia J. Cardiac carnitine leakage is promoted by cardiomyopathy.

Nutrition 21(3) (2005): 348-50. Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V. Carnitine and hemodialysis. Am J Kidney Dis

41(3 Suppl 1) (2003): SI 16-22. Benvenga S et al. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 86(8) (2001): 3579-94. Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU Int 88(1) (2001): 63-7. Bianchi G et al. Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur J Cancer 41(12) (2005): 1746-50. Binienda Z, Virmani A, Przybyla-Zawislak B, Schmued L. Neuroprotective effect of carnitine in the 3-

nitropropionic acid (3-NPA)-evoked neurotoxicity in rats. Neurosci Lett 367(2) (2004): 264-7. Brevetti G et al. Increases in walking distance in patients with peripheral vascular disease treated with L-

carnitine: a double-blind, crossover study. Circulation 77 (4) (1988): 767-73. Brooks JO et al. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach. Int Psychogeriatr 10(2) (1998): 193203.

Campos Y et al. Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 16(2) (1993): 150-3. Cherchi A et al. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, doubleblind, randomized, placebo controlled crossover study. Int J Clin Pharmacol Ther Toxicol 23(10) (1985): 569-72.

Corbucci GG, Lettieri B. Cardiogenic shock and L-carnitine: clinical data and therapeutic perspectives. Int J

Clin Pharmacol Res 11(6) (1991): 283-93. Corbucci GG, Loche F. L-carnitine in cardiogenic shock therapy: pharmacodynamic aspects and clinical data.

Int J Clin Pharmacol Res 13(2) (1993): 87-91. Costa M et al. L-carnitine in idiopathic asthenozoospermia: a multicentre study. Andrologia 26 (1994): 155-9. Curione M et al. Carnitine deficiency in patients with coeliac disease and idiopathic dilated cardiomyopathy.

Nutr Metab Cardiovasc Dis 15(4) (2005): 279-83. Dalakas MC et al. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency Carnitine 193

and lipid storage. Ann Neurol 35 (1994): 482-7.

Davini P, Bigalli A, Lam anna F, Boem A. Controlled study on L-carnitine therapeutic efficacy in post-infarction. Drugs Exp Clin Res 18(8) (1992): 355-65.

De Grandis D, Minardi C. Acetyl-L-carnitine (levace car nine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study. Drugs RD 3(4) (2002): 223-31.

Derosa G, Cicero AF, Gaddi A, Mugellini A, Ciccarelli L, Fogari R. The effect of L-carnitine on plasma lipoprotein (a) levels in hype rcholeste role mic patients with type 2 diabetes me Hit us. Clin Ther 25(5) (2003): 1429-39.

Ellaway C et al. Rett syndrome: randomized controlled trial of L-carnitine. J Child Neurol 14(3) (1999): 162-7.

Eskandari HG, Cimen MYB, Tamer L, Kanik A, Atik U. Short term effects of L-carnitine on serum lipids in STZ-induced diabetic rats. Diabetes Res Clin Pract 66(2) (2004): 129-32.

Evangeliou A, Vlassopoulos D. Carnitine metabolism and deficit: When is supplementation necessary? Curr Pharm Biotechnol 4(3) (2003): 211-19.

Fernandez C, Proto C. L-carnitine in the treatment of chronic myocardial ischemia: An analysis of 3 multicenter studies and a bibliographic review. Clin Ther 140(4) (1992): 353-77 [in Italian].

Garolla A, Maiorino M, Roverato A, RoveriA, Ursini F, Foresta C. Oral carnitine supplementation increases sperm motility in asthenozoospermic men with normal sperm phospholipid hydroperoxide glutathione peroxidase levels. Fertil Steril 83(2) (2005): 355-61.

Garzya G. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression. Drugs Exp Clin Res 16(2) (1990): 101-6.

Genger H, Enzelsberger H, Salzer H. Carnitine in therapy of placental insufficiency: initial experiences. Z Geburtshilfe Perinatol 192 (1988): 155-7.

Grandi M, Pederzoli A, Sacchetti C. Effect of acute carnitine administration on glucose insulin metabolism in healthy subjects. IntJ Clin Pharm Res 17(4) (1997): 143-7.

Graziano F et al. Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. Br J Cancer 86(12) (2002): 1854-7.

Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci 78(8) (2006): 803-11.

Gunes B, Yalcin SS, Kalkanoglu HS, Onol S, Dursun A, Coskun T. The effect of oral L-carnitine supplementation on the lipid profiles of hyperlipidaemic children. Acta Paediatr 94(6) (2005): 711-16.

Harper P, Elwin CE, Cederblad G. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol 35 (1988): 555-62.

Hendler SS, Rorvik D (eds). PDRfor Nutritional Supplements. Montvale, NJ: Medical Economics Co., 2001.

Hiatt WRet al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 110(8) (2001): 616-22.

Hino K, Nishikawa M, Sato E, Inoue M. 1-Carnitine inhibits hypoglycemia-induced brain damage in the rat. Brain Res 1053(1-2) (2005): 77-87.

Hug G et al. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin and carmazepine in children. J Pediatr 119 (1991): 799-802.

I lias I, Manoli I, Blackman MR, Gold PW, Ale sci S. L-Carnitine and acetyl-L-carnitine in the treatment of complications associated with HIV infection and antiretroviral therapy. Mitochondrion 4(2-3) (2004): 1638.

Ishii T, Shimpo Y, Matsuoka Y, Kinoshita K. Anti-apoptotic effect of acetyl-L-carnitine and L-carnitine in primary cultured neurons. Jpn J Pharmacol 83(2) (2000): 119-24.

Iyer RN, Khan AA, Gupta A, Vajifdar BU, Lokhandwala YY. L-carnitine moderately improves the exercise tolerance in chronic stable angina. J Assoc Physicians India 48(11) (2000): 1050-2.

Jones MG, Goodwin CS, Amjad S, Chalmers RA. Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome. Clin Chim Acta 360(1-2) (2005): 173-7.

Karakoc E, Erdem S, Sokmensuer C, Kansu T. Encephalopathy due to carnitine deficiency in an adult patient with gluten enteropathy. Clin Neurol Neurosurg 2005 [Epub ahead of print]. Carnitine lV^r

Karlic H, Lohninger A. Supplementation of L-carnitine in athletes: does it make sense? Nutrition 20(7-8) (2004): 709-15.

Kawasaki N et al. Long-term L-carnitine treatment prolongs the survival in rats with andiamycin induced heart failure. J Card Fail 2 (1996): 293-9.

Kelly GS. L-Carnitine: Therapeutic applications of a conditionally-essential amino acid. Altern Med Rev 3(5) (1998): 345-60.

Kletzmayr J et al. Anemia and carnitine supplementation in hemodialyzed patients. Kidney Int 55(69) (1999): S93-106.

Kosan C, Sever L, Arisoy N, Caliskan S, Kasapcopur O. Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients. Pediatr Nephrol 18(11) (2003): 1184-8.

Krahenbuhl S. Carnitine metabolism in chronic liver disease. Life Sci 59(19) (1996): 1579-99.

Kumar M, Kabra NS, Paes B. Carnitine supplementation for preterm infants with recurrent apnea. Cochrane Database Syst Rev (4) (2004a): CD004497.

Kumar M, Kabra NS, Paes B. Role of carnitine supplementation in apnea of prematurity: a systematic review. J Perinatol 24(3) (2004b): 158-63.

Kurz C et al. L-carnitine-betamethasone combination therapy versus betamethasone therapy alone in prevention of respiratory distress syndrome. Z Geburtshilfe Perinatol 197(5) (1993): 215-19 [in German].

Lenzi A et al. Metabolism and action of L-carnitine: its possible role in sperm tail function. Arch Ital Urol Nephrol Androl 64 (1992): 187-96.

Lenzi A et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril 79(2) (2003): 292-300.

Li B et al. The effect of enteral carnitiine administration in humans. Am J Clin Nutr 55 (1992): 838-45.

Lissoni P et al. Prevention by L-carnitine of interleukin-2 related cardiac toxicity during cancer immunotherapy. Tumori 79 (1993): 202-4.

Loster H et al. Prolonged oral L-carnitine substitution increases bicycle ergometer performance in patients with severe, ischemic ally induced cardiac insufficiency. Cardiovasc Drugs Ther 13(6) (1999): 537-46.

LoVecchio F, Shriki J, Samaddar R. l-carnitine was safely administered in the setting of valproate toxicity. Am J Emerg Med 23(3) (2005): 321-2.

Maestri A, De Pasquale Ceratti A, Cundari S, Zanna C, Cortesi E, Crino L. A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy. Tumori 91(2) (2005): 135-8.

Malaguarnera M et al. L-Carnitine in the treatment of mild or moderate hepatic encephalopathy. Dig Dis 21(3) (2003): 271-5.

Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S. Carnitine deficiency in children and adolescents with type 1 diabetes. J Diabetes Complic 18(5) (2004): 271-4.

Martindale W. Martindale, Extra Pharmacopoeia. London: Pharmaceutical Press, 1999.

Martinez E, Domingo P, Roca-Cusachs A. Potentiation of acenocoumarol action by L-carnitine (Letter). J Intern Med 233 (1993): 94.

Matera M et al. History of L-carnitine: implications for renal disease. J Renal Nutr 13(1) (2003): 2-14.

Matera M, Bellinghieri G, Costantino G, Santoro D, Calvani M, Savica V. History of L-carnitine: implications for renal disease. J Renal Nutr 13(1) (2003): 2-14.

Moretti S et al. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal 4(3) (2002): 391-403.

Negro P et al. The effect of L-carnitine, administered through intravenous infusion of glucose, on both glucose and insulin levels in health subjects. Drugs Exp Clin Res 20(6) (1994): 257-62.

Neri S et al. L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C. Neuropsychobiology 47(2) (2003): 94-7.

ODonnell J, Finer NN, Rich W, Barshop BA, Barrington KJ. Role of L-carnitine in apnea of prematurity: a randomized, controlled trial. Pediatrics 109(4) (2002): 622-6.

Onofrj M et al. L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain. Int J Clin

Pharmacol Res 15(1) (1995): 9-15. Carnitine 195

Peluso G et al. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 182 (2000): 339-50.

PettegrewJW et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging 16(1) (1995): 1-4.

Pistone G et al. Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue. Drugs Aging 20(10) (2003): 761-7.

Plioplys AV, Kasnicka I. L-carnitine as a treatment for Rett syndrome. South MedJ 86(12) (1993): 1411-12.

Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology 35(1) (1997): 16-23.

Plioplys AV, Plioplys S. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 32(3) (1995): 132-8.

Rahbar AR, Shakerhosseini R, Saadat N, Taleban F, Pordal A, Gollestan B. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 59(4) (2005): 5926.

Ramos AC, Barrucand L, Elias PR, Pimentel AM, Pires VR. Carnitine supplementation in diphtheria. Indian Pediatr 29(12) (1992): 1501-5.

Ramos AC, Elias PR, Barrucand L, Da Silva JA. The protective effect of carnitine in human diphtheric myocarditis. Pediatr Res 18(9) (1984): 815-19.

Rebouche CJ, Chenard CA. Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J Nutr 121 (1991): 539-45.

Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. Am Heart J 139(2) (2000): S120-3.

Rodriguez-Segade S et al. Carnitine deficiency associated with anticonvulsant therapy. Clin Chim Acta 181(2) (1989): 175-81.

Sano M et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Arch Neurol 49(11) (1992): 1137-41.

Savitha S, Sivarajan K, Haripriya D, Kokilavani V, Panneerselvam C. Efficacy of levo carnitine and alpha lipoic acid in ameliorating the decline in mitochondrial enzymes during aging. Clin Nutr 24(5) (2005): 794-800.

Semino-Mora MC et al. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes: Part 1: L-carnitine prevents the myotoxicity of AZT in vitro. Lab Invest 71 (1994): 102-12.

Sigma-Tau Pharmaceuticals. Carnitor [levocarnitine] package insert. Gaithersberg, MD: Sigma-Tau Pharmaceuticals Inc., Dec. 1999.

Singh RB et al. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Postgrad MedJ 72(843) (1996): 45-50.

Sir tori CR et al. L-carnitine reduces plasma lipoprotein (a) levels in patients with hyper Lp(a). Nutr Metab Cardiovasc Dis 10(5) (2000): 247-51.

Soetekouw PM et al. Normal carnitine levels in patients with chronic fatigue syndrome. Neth J Med 57(1) (2000): 20-4.

Sorbi S, Forleo P, Fani C, Piacentini S. Double-blind, crossover, placebo-controlled clinical trial with L-

acetylcarnitine in patients with degenerative cerebellar ataxia. Clin Neuropharmacol 23(2) (2000): 114-18.

Steinman TI et al. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking: or were they? Nephrol News Issues 17(5) (2003): 28-30, 32-4, 36 passim.

Tastekin A, Gepdiremen A, Ors R, Emin Buyukokuroglu M, Halici Z. l-carnitine protects against glutamate- and kainic acid-induced neurotoxicity in cerebellar granular cell culture of rats. Brain Dev 27(8) (2005): 570-3.

Tempesta E et al. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism. Int J Clin Pharmacol Res 10(1-2) (1990): 101-7.

Thai LJ et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology 47(3) (1996): 705-11.

Tomassini V et al. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci 218(1-2) (2004): Carnitine iyt)

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment